Literature DB >> 7650724

The detection of raised levels of IgM to Proteus mirabilis in sera from patients with rheumatoid arthritis.

B W Senior1, P D McBride, K D Morley, M A Kerr.   

Abstract

An analysis by ELISA of 100 rheumatoid factor (RF)-positive sera selected at random from a collection of sera from patients with various auto-immune diseases and joint pains, and 100 RF-negative sera from the same collection matched by patient age and gender, showed that the RF-positive sera had highly significantly (p < 0.0001) raised levels of IgM antibody, but not IgG antibody, to Proteus mirabilis over those of the RF-negative sera. This response was subsequently found to be associated with sera from patients who clinically had rheumatoid arthritis (RA). Sera from the RA patients had significantly greater amounts (p = 0.026) of IgM antibody to P. mirabilis than to the other organisms tested and these values were also highly significantly different (p < 0.0001) from P. mirabilis IgM antibody levels in matched RF-negative sera. Sera from RA patients also had significantly greater amounts of IgA to P. mirabilis (p < 0.0001) and greater amounts of IgM to Escherichia coli (p < 0.0001) and Klebsiella pneumoniae (p < 0.0001) than those in matched RF-negative sera. Other classes of antibody to these organisms and all classes of antibody to Pseudomonas aeruginosa were not raised in the sera of RA patients over those of RF-negative controls. The IgM response in RA patients was not specific for only one O serotype of P. mirabilis but was associated with all 11 different O serotypes of P. mirabilis tested and those of other Proteus spp. Moreover, the IgM antibodies to Proteus spp. appeared to be independent from C-reactive protein and RF.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7650724     DOI: 10.1099/00222615-43-3-176

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  7 in total

Review 1.  Potential virulence factors of Proteus bacilli.

Authors:  A Rózalski; Z Sidorczyk; K Kotełko
Journal:  Microbiol Mol Biol Rev       Date:  1997-03       Impact factor: 11.056

2.  Cross-reactivity between the rheumatoid arthritis-associated motif EQKRAA and structurally related sequences found in Proteus mirabilis.

Authors:  H Tiwana; C Wilson; A Alvarez; R Abuknesha; S Bansal; A Ebringer
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

3.  DNA gyrase and topoisomerase IV mutations associated with fluoroquinolone resistance in Proteus mirabilis.

Authors:  L M Weigel; G J Anderson; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

4.  The gut-joint axis: cross reactive food antibodies in rheumatoid arthritis.

Authors:  M Hvatum; L Kanerud; R Hällgren; P Brandtzaeg
Journal:  Gut       Date:  2006-02-16       Impact factor: 23.059

5.  Anti-Proteus activity of some South African medicinal plants: their potential for the prevention of rheumatoid arthritis.

Authors:  I E Cock; S F van Vuuren
Journal:  Inflammopharmacology       Date:  2013-07-23       Impact factor: 4.473

6.  Antibacterial and antipeptide antibodies in Japanese and Finnish patients with rheumatoid arthritis.

Authors:  T Rashid; M Leirisalo-Repo; Y Tani; S Hukuda; S Kobayashi; C Wilson; S Bansal; A Ebringer
Journal:  Clin Rheumatol       Date:  2004-02-13       Impact factor: 2.980

7.  The potential of selected Australian medicinal plants with anti-Proteus activity for the treatment and prevention of rheumatoid arthritis.

Authors:  I E Cock; V Winnett; J Sirdaarta; B Matthews
Journal:  Pharmacogn Mag       Date:  2015-05       Impact factor: 1.085

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.